A pharmaceutical company targeting unmet clinical needs.

Herantis Pharma was created by a merger of two pharmaceutical companies, Hermo Pharma and Laurantis Pharma.

Pipeline

Overview

Herantis has a product development portfolio focused in areas of unmet clinical need, based on internationally recognized science.

Read More

Herantis Pharma Plc publishes introductory video on its Lymfactin® with the leading lymphedema advocacy group LE&RN

Herantis Pharma Plc publishes introductory video on its Lymfactin® with the leading lymphedema advocacy group LE&RN Herantis Pharma Plc Press…

Read More

Herantis Pharma plc sponsors first CDNF MANF Symposium

Herantis Pharma plc sponsors first CDNF MANF Symposium Herantis Pharma Plc Press release 10 Jan 2017 at 9:00 am Herantis…

Read More

Herantis Pharma's Manager's Transactions

Herantis Pharma's Manager's Transactions Herantis Pharma Plc Company release 2 Jan 2017 at 9:00 am Herantis Pharma Oyj - Managers'…

Read More

Investors

Herantis shares are listed on NASDAQ OMX Helsinki First North Finland. Read More

New therapies for a better life.